...
首页> 外文期刊>Intensive care medicine >Bronchoalveolar lavage with a diluted surfactant suspension prior to surfactant instillation improves the effectiveness of surfactant therapy in experimental acute respiratory distress syndrome (ARDS).
【24h】

Bronchoalveolar lavage with a diluted surfactant suspension prior to surfactant instillation improves the effectiveness of surfactant therapy in experimental acute respiratory distress syndrome (ARDS).

机译:在滴注表面活性剂之前用稀释的表面活性剂悬浮液进行支气管肺泡灌洗可以提高表面活性剂治疗实验性急性呼吸窘迫综合征(ARDS)的有效性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To assess whether bronchoalveolar lavage (BAL) with a diluted surfactant suspension prior to surfactant instillation prevents the only transient improvement in lung function as reported after surfactant instillation in severe acute respiratory distress syndrome (ARDS). DESIGN: Randomized, prospective, experimental study. SETTING: Laboratory and animal facility of a large university. MATERIALS: Adult male Sprague-Dawley rats (280 +/- 30 g). INTERVENTIONS: All animals underwent repetitive whole lung saline lavage to induce acute lung injury. Then, animals were randomly divided into seven study groups: the first group received surfactant (150 mg/ kg) within 10 min after the last lavage (early treatment), whereas in the other six groups mechanical ventilation was continued for 3 h before treatment (late treatment). Treatment consisted of: surfactant instillation at a dose of 150 mg/kg; at a dose of 250 mg/kg; BAL with saline; BAL with a diluted surfactant suspension (2.5 mg/ml); BAL with saline, immediately followed by surfactant instillation (150 mg/kg) and BAL with a diluted surfactant suspension (2.5 mg/kg), immediately followed by surfactant instillation (150 mg/kg). MEASUREMENTS AND RESULTS: Blood gases were measured for 6 h and then BAL was performed to measure the protein concentration and surface tension properties. Mean PaO2 values increased immediately after surfactant instillation to pre-lavage values but remained stable only in the group that received surfactant immediately after the lavage procedure and the group that underwent BAL with a diluted surfactant suspension prior to surfactant instillation. CONCLUSION: BAL with a diluted surfactant suspension prior to surfactant instillation at a later time point in lung injury resulted in a stable improvement of lung function. This improvement is comparable with the results seen after surfactant instillation immediately after lung lavage.
机译:目的:评估在重度急性呼吸窘迫综合征(ARDS)中表面活性剂滴注后,在表面活性剂滴注前用稀释的表面活性剂悬浮液稀释支气管肺泡灌洗液(BAL)是否能防止肺功能的唯一短暂改善。设计:随机,前瞻性,实验研究。地点:大型大学的实验室和动物设施。材料:成年雄性Sprague-Dawley大鼠(280 +/- 30g)。干预措施:所有动物均进行重复性全肺盐水灌洗,以引起急性肺损伤。然后,将动物随机分为七个研究组:第一组在最后一次灌洗(早期治疗)后10分钟内接受表面活性剂(150 mg / kg),而其他六组在治疗前继续进行机械通气3 h(后期治疗)。处理包括:以150 mg / kg的剂量滴注表面活性剂;剂量为250 mg / kg; BAL加盐水;具有稀释的表面活性剂悬浮液(2.5 mg / ml)的BAL; BAL加盐水,然后立即滴加表面活性剂(150 mg / kg),BAL加稀释的表面活性剂悬浮液(2.5 mg / kg),然后立即滴加表面活性剂(150 mg / kg)。测量和结果:测量血气6小时,然后进行BAL测量蛋白浓度和表面张力特性。表面活性剂滴注后,平均PaO2值立即增加至灌洗前的值,但仅在灌洗程序后立即接受表面活性剂的组和在表面活性剂滴注前经过稀释的表面活性剂悬浮液进行BAL的组中,才保持稳定。结论:在肺损伤后期,在表面活性剂滴注之前先用稀释的表面活性剂悬浮液配制的BAL可稳定改善肺功能。这种改善与肺灌洗后立即滴注表面活性剂后看到的结果相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号